Cosmc Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Cosmc Antibodies for investigating Core 1 β3-Galactosyltransferase (Cosmc) protein function. Cosmc Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Core 1 β3-Galactosyltransferase plays a vital role in protein glycosylation, which influences cell signaling and immune responses. Alterations in glycosylation patterns can significantly impact tumor progression and metastasis, making Cosmc research particularly relevant in cancer biology. Scientists can examine Cosmc expression patterns across different tissues and cellular compartments to better understand its biological functions. Advanced research techniques allow for detailed analysis of glycosylation mechanisms and their effects on cellular processes. Investigating Cosmc activity provides valuable insights into potential therapeutic targets and biomarkers for various diseases. Santa Cruz Biotechnology monoclonal antibodies for Cosmc research enable scientists worldwide to advance our understanding of glycosylation in health and disease.